Bringing the fundamentals into focus…
Back to Royalty Pharma plc
How Royalty Pharma plc stacks up
RPRX · against 67 other Healthcare companies of similar size
Growth
38/ 100
Near the bottom of its peers.
Ranked #57 of 68 · scores higher than 16% of peers
Bars: peers in each 10-point band of the growth score3 peers with a growth score of 30–39, including RPRX · Click a bar to see the companies
Why growth scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 76% of peers. Earnings per share growth: -19.9% vs peer median 9.8%
- slower revenue growth over three years: weaker than 64% of peers. 3-year revenue growth: 2.4% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 61% of peers. Revenue growth: 10.0% vs peer median 6.1%
Metric by metric
Position: dot = RPRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 69 reported | 10.0% | 11.9% | 49% | 33% | |
| Earnings per share growthHigher is better · 52 reported | -19.9% | 14.0% | 14% | 33% | |
| 3-year revenue growthHigher is better · 68 reported | 2.4% | 8.2% | 24% | 33% |
Ranking by growth score
Top 5 and the companies ranked around RPRX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 56.7B USD | 96 | 79 | |
| 3 | 22.8B USD | 95 | 38 | |
| 4 | 40.2B USD | 92 | 73 | |
| 5 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 53 | 95.4B AUD (≈$62.9B) | 42 | 48 | |
| 53 | 34.3B USD | 42 | 57 | |
| 55 | 54.9B USD | 40 | 59 | |
| 56 | 36.4B USD | 39 | 50 | |
| 57 | 38.4B USD | 38 | 50 | |
| 58 | 38.9B USD | 36 | 56 | |
| 59 | 64.8B EUR (≈$71.3B) | 29 | 51 | |
| 60 | 154.4B BRL (≈$27.8B) | 28 | 43 | |
| 61 | 36.0B USD | 27 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score